5 Results for "

SNX21

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "SNX21" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-10214
CAS No.: 908112-43-6
Purity:  99.49%
Synonyms: PF-04928473
Target:  

HSP Autophagy

Research Areas:  

Cancer

SNX-2112 (PF 04928473) is an orally active Hsp90 inhibitor, with a Kd of 16 nM for Hsp90 and IC50s of 30 nM, 30 nM for Hsp90 α and Hsp90 β, also induces Her-2 degradation, and inhibits Grp94 and Trap-1, with IC50s of 10 nM, 4.275 μM and 0.862 μM, respectively . SNX-2112 (PF 04928473) binds Hsp90 isoforms Hsp90α, Hsp90β and Hsp90b1/Grp94 with Kds of 4 nM, 6 nM and 484 nM, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-101800
CAS No.: 1449228-40-3
Purity:  99.09%
Synonyms: SNX2-1-165; BCD-115
Target:  

CDK

Research Areas:  

Cancer

Senexin B (SNX2-1-165; BCD-115) is a potent, highly water-soluble and bioavailable CDK8/19 inhibitor, with Kds of 140 nM for CDK8 and 80 nM for CDK19.
loading...
    loading...
Cat. No.: HY-117988
CAS No.: 1366002-73-4
Target:  

CDK

Research Areas:  

Others

SNX2-1-108 is a CDK8 kinase inhibitor.
loading...
    loading...
Cat. No.: HY-10214R
CAS No.: 908112-43-6
Synonyms: PF-04928473 (Standard)
Research Areas:  

Cancer

SNX-2112 (Standard) is the analytical standard of SNX-2112 (HY-10214). This product is intended for research and analytical applications. SNX-2112 (PF 04928473) is an orally active Hsp90 inhibitor, with a Kd of 16 nM for Hsp90 and IC50s of 30 nM, 30 nM for Hsp90 α and Hsp90 β, also induces Her-2 degradation, and inhibits Grp94 and Trap-1, with IC50s of 10 nM, 4.275 μM and 0.862 μM, respectively . SNX-2112 (PF 04928473) binds Hsp90 isoforms Hsp90α, Hsp90β and Hsp90b1/Grp94 with Kds of 4 nM, 6 nM and 484 nM, respectively .
loading...
    loading...
Cat. No.: HY-101800R
CAS No.: 1449228-40-3
Synonyms: SNX2-1-165 (Standard); BCD-115 (Standard)
Target:  

Reference Standards CDK

Research Areas:  

Cancer

Senexin B (Standard) (SNX2-1-165 (Standard)) is the analytical standard of Senexin B (HY-101800). This product is intended for research and analytical applications. Senexin B (SNX2-1-165; BCD-115) is a potent, highly water-soluble and bioavailable CDK8/19 inhibitor, with Kds of 140 nM for CDK8 and 80 nM for CDK19.
loading...
    loading...